eli lilly obesity - Search News

Eli Lilly launches anti-obesity drug in India

Bloomberg · 2d

Eli Lilly First to Launch Weight Loss Drug in Obesity-Hit India

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a country that has the world’s third-largest number of obese people.

Reuters on MSN · 1d

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes.

The Times of India on MSN · 1d

Mounjaro: As Eli Lilly's blockbuster anti-obesity drug comes to India, expert lists key side effects

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with weight management and activates hormone receptors. Potential side effects include gastrointestinal issues,

Fierce Pharma1d

Lilly backs study in mission to improve Hollywood representations of obesity, diabetes, dementia and more

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

Eli Lilly’s Dave Ricks takes home $114 million as obesity drugs fuel company’s fortunes

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results